Database analyses including the Oncomine and TCGA gene expression database show a high expression of CD96 in brain cancer, breast cancer, head-and-neck squamous cell carcinoma (HNSCC), and other malignant diseases but a low expression in lung cancer, rectal cancer, and others [15,18]. This evidence concerns the gene CD96 and breast cancer.